© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
September 01, 2020
Investigators report on a post-hoc analysis of the EMPA-REG OUTCOME trial that assesses the efficacy of the SGLT-2 inhibitor in patients with obstructive sleep apnea.
The new equation model has shown to be more accurate than the Framingham Lifetime Risk equation and Pooled Cohort Equation.
August 31, 2020
New data shows that high BMI individuals who were in the lowest polygenic score quintile had a 5-fold greater risk of diabetes than those with low BMI and a high polygenic score.
August 30, 2020
Dapagliflozin and empagliflozin are shown to minimize CV events in patients with heart failure and a reduced ejection fraction.
August 28, 2020
The system maintains tight glucose control and reduces the risk of hypoglycemia.
August 14, 2020
A single nucleotide polymorphism is associated with severe and proliferative retinopathy risk reduction by 42% and 63%, respectively.
August 12, 2020
Treatment with the PCSK9 Inhibitor did not increase risk of safety events, including new-onset diabetes.
August 05, 2020
Older, white patients and those who use linagliptin are at a higher risk of bullous pemphigoid.
July 28, 2020
Eyes with moderate to severe nonproliferative diabetic retinopathy more often develop eye worsening compared to those with a milder form of the condition.
A total of 115 of 200 examined eyes had some form of diabetic retinopathy in data presented at the ASRS 2020 virtual meeting.